Company Profile
ICU Medical Stock Price, News & Analysis
- Ticker:
- ICUI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
166.37 USD (-0.02%)
Close
Last updated: August 6, 2026
3.26B USD
Market cap
Why the stock is moving
The latest monitored company update is “ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance.” The corresponding closing-price reaction is not yet available.
Company overview
Infusion and Critical Care
ICU Medical develops, manufactures and sells medical products used to deliver therapies and manage critically ill patients. Its portfolio serves hospitals, alternate-care sites and home-care settings worldwide.
Infusion Systems
The company supplies infusion systems that control and monitor the delivery of intravenous medications and fluids. These platforms form the equipment layer of its infusion offering.
Recurring Consumables
ICU Medical also provides infusion consumables used alongside installed systems, creating a recurring product relationship with clinical customers.
Vital Care Products
The Vital Care portfolio includes high-value critical-care products and selected contract-manufacturing activities, extending the business beyond infusion equipment and disposables.
Future catalysts
ICU Medical’s catalysts are infusion-system replacement cycles, margin recovery, and operating discipline across the product portfolio. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
Recent news
- 01
- 02
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
Source: ICU Medical
- 03
ICU Medical Announces First Quarter 2026 Results
Source: ICU Medical
- 04
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
Source: ICU Medical
- 05
ICU Medical to Participate in Upcoming Investor Conferences
Source: ICU Medical
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ICU Medical (ICUI)?
ICU Medical (ICUI) most recently closed at 166.37 USD, a -0.02% move versus the previous session.
What is the market cap of ICU Medical (ICUI)?
ICU Medical currently has a market capitalization of 3.26B USD on BioPharmSignal.
What does ICU Medical do?
Infusion and Critical Care ICU Medical develops, manufactures and sells medical products used to deliver therapies and manage critically ill patients. Its portfolio serves hospitals, alternate-care sites and home-care settings worldwide. Infusion Systems The company supplies infusion systems that control and monitor the delivery of intravenous medications...
On which exchange is ICUI stock listed?
ICU Medical (ICUI) is associated with NASDAQ, United States, Biopharma.
What is Infusion?
ICU Medical’s catalysts are infusion-system replacement cycles, margin recovery, and operating discipline across the product portfolio.
Which conditions is ICU Medical targeting with Infusion?
ICU Medical’s catalysts are infusion-system replacement cycles, margin recovery, and operating discipline across the product portfolio.
How does ICU Medical describe recent progress with Infusion?
ICU Medical’s catalysts are infusion-system replacement cycles, margin recovery, and operating discipline across the product portfolio.
What is Critical?
Infusion and Critical Care ICU Medical develops, manufactures and sells medical products used to deliver therapies and manage critically ill patients.